You are here
An intravenous injection of a talc-containing drug
Fibrosing interstitial lung disease - An intravenous injection of a talc-containing drug Factor
Last reviewed for CCPS 16 December 2009.
Preliminary questions [40657]
40679 there is some evidence that intravenous injection of a talc-containing drug may be a factor in the development or worsening of the condition under consideration.
41042 the veteran has received an intravenous injection of a talc-containing drug intended for oral use at some time. 41043 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for fibrosing interstitial lung disease. 41044 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for the clinical onset of fibrosing interstitial lung disease. 41046 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and operational service for the clinical onset of fibrosing interstitial lung disease. or 41047 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and eligible service for the clinical onset of fibrosing interstitial lung disease. or 41045 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for the clinical worsening of fibrosing interstitial lung disease. 41048 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and operational service for the clinical worsening of fibrosing interstitial lung disease. or 41049 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and eligible service for the clinical worsening of fibrosing interstitial lung disease. Clinical onset and operational service [41046] Clinical onset and eligible service [41047] Clinical worsening and operational service [41048] Clinical worsening and eligible service [41049]